Morio R, Takazono T, Kubo R, Fukushima K, Suyama N, Izumikawa T, Izumikawa K, Yanagihara K, Mukae H.: Survey of Advance Care Planning Practices in Elderly COVID-19 Patients: A Multicenter Questionnaire Survey. Cureus 15(5): 2023.10.7759/cureus.39663.. (IF: NA)
Koga S, Takazono T, Kido T, Muramatsu K, Tokutsu K, Tokito T, Okuno D, Ito Y, Yura H, Takeda K, Iwanaga N, Ishimoto H, Sakamoto N, Yatera K, Izumikawa K, Yanagihara K, Fujino Y, Fushimi K, Matsuda S, Mukae H.: Evaluation of the Effectiveness and Use of Anti-Methicillin-Resistant Staphylococcus aureus Agents for Aspiration Pneumonia in Older Patients Using a Nationwide Japanese Administrative Database. Microorganisms 11(8): 1905,2023.10.3390/microorganisms11081905.. (IF: 4.5)
Takazono T, Ngwe Tun MM, Funakoshi S, Morimoto S, Ota K, Torigoe K, Abe S, Muta K, Ito Y, Ashizawa N, Kitamura M, Takeda K, Iwanaga N, Ide S, Tashiro M, Hosogaya N, Nishino T, Yanagihara K, Izumikawa K, Morita K, Mukae H.: Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis Patients. Kidney Int Rep 8(9): 1883-1886,2023.10.1016/j.ekir.2023.06.008.. (IF: 6)
Ashizawa N, Takazono T, Ito Y, Nakada N, Hirayama T, Takeda K, Ide S, Iwanaga N, Tashiro M, Hosogaya N, Yanagihara K, Mukae H, Izumikawa K.: Antifungal susceptibility profiles of Cryptococcus neoformans strains clinically isolated from non-HIV-infected patients in Nagasaki, Japan. Med Mycol 61(10): myad100,2023.10.1093/mmy/myad100.. (IF: 2.9)
Tashiro M, Takazono T, Izumikawa K.: Invasive Malassezia Infections.. Med Mycol J 64(4): 79-83,2023.10.3314/mmj.23-003. (IF: 1)
Tanaka T, Tashiro M, Ota K, Fujita A, Sawai T, Kadota J, Fukuda Y, Sumiyoshi M, Ide S, Tachikawa N, Fujii H, Hibino M, Shiomi H, Izumida M, Matsui K, Yamauchi M, Takahashi K, Yamanashi H, Sugimoto T, Akabame S, Umeda M, Shimizu M, Hosogaya N, Kosai K, Takeda K, Iwanaga N, Ashizawa N, Hirayama T, Takazono T, Yamamoto K, Imamura Y, Miyazaki T, Kobayashi Y, Ariyoshi K, Mukae H, Yanagihara K, Kita K, Izumikawa K: Safety and efficacy of 5-aminolevulinic acid phosphate/iron in mild-to-moderate coronavirus disease 2019: A randomized exploratory phase II trial. Medicine (Baltimore) 102(34): e34858,2023.10.1097/MD.0000000000034858. (IF: 1.6)
Ozasa M, Bychkov A, Zaizen Y, Tabata K, Uegami W, Yamano Y, Kataoka K, Johkoh T, Mukae H, Kondoh Y, Fukuoka J.: Effect of the 2020 hypersensitivity pneumonitis guideline on the pathologic diagnosis of interstitial pneumonia.. : 2023.10.1038/s41598-023-35986-9. (IF: 4.6)
Moriyama S, Kido T, Sakamoto N, Fuchigami M, Tokito T, Okuno D, Miyamura T, Nakashima S, Hara A, Ishimoto H, Imaizumi Y, Tsuruda K, Yanagihara K, Fukuoka J, Mukae H.: Pulmonary Nodular Lymphoid Hyperplasia Evaluated with Bronchoalveolar Lavage Fluid Findings: A Case Report and Review of the Literature on Japanese Patients. Intern Med 62(1): 95-102,2023.10.2169/internalmedicine.9310-21.. (IF: 1.2)
Tanaka Y, Kido T, Sakamoto N, Hara A, Kato T, Miyashita R, Ozasa M, Tokito T, Okuno D, Takeda K, Yura H, Takemoto S, Takazono T, Ishimoto H, Obase Y, Ishimatsu Y, Miyazaki Y, Mukae H.: Lung Involvement in Adult T-Cell Lymphoma Diagnosed Using Bronchoscopic Cryobiopsy: A Case Report and Review of the Literature. Medicina 59(11): 2015,2023.0.3390/medicina59112015.. (IF: 2.9)
Tokito T, Kido T, Muramatsu K, Tokutsu K, Okuno D, Yura H, Takemoto S, Ishimoto H, Takazono T, Sakamoto N, Obase Y, Ishimatsu Y, Fujino Y, Yatera K, Fushimi K, Matsuda S, Mukae H.: Impact of Administering Intravenous Azithromycin within 7 Days of Hospitalization for Influenza Virus Pneumonia: A Propensity Score Analysis Using a Nationwide Administrative Database. Virusses 15(5): 1142,2023.10.3390/v15051142.. (IF: 4.7)
Ogata R, Kido T, Takeda K, Nemoto K, Heima R, Takao M, Miyashita R, Ozasa M, Tokito T, Okuno D, Ito Y, Yura H, Koga T, Hashimoto K, Takemoto S, Takazono T, Ishimoto H, Sakamoto N, Fukuda K, Sasaki Y, Obase Y, Ishimatsu Y, Yatera K, Izumikawa K, Mukae H.: Disseminated Mycobacterium genavense Infection Mimicking Sarcoidosis: A Case Report and Review of Literature on Japanese Patients. Microorganisms 11(9): 2145,2023.10.3390/microorganisms11092145.. (IF: 4.8)
Kazumasa Akagi , Kiyoyasu Fukushima, Ritsuko Miyashita , Akira Kondo, Yuko Kaneko, Naomi Ehara, Shintaro Yoshida, Hirokazu Taniguchi, Hiroyuki Yamaguchi, Hiroshi Mukae, Isao Sano, Hideki Taniguchi, Kazuto Shigematsu: Long-term survival after chemotherapy and salvage lobectomy for multiple station N2 stage IIIA non-small cell lung cancer: A case report. ACTA MEDICA NAGASAKIENSIA 67(1): 31-36,2023.NA. (IF: NA)
Hayashi F, Akagi K, Taniguchi H, Matsutake T, Kawahara H, Sekine I, Gyotoku H, Takemoto S, Soda H, Ashizawa K, Mukae H: TIM-3 expression induces resistance to PD-1 inhibitor in G-CSF-producing lung spindle cell carcinoma: A case report. Thorac Cancer 14(36): 3501-3560,2023.10.1111/1759-7714.15149. (IF: 2.9)
Mine K, Sakamoto N, Ozasa M, Tsutsui S, Miyashita R, Tokito T, Okuno D, Yura H, Kido T, Ishimoto H, Takemoto S, Takazono T, Obase Y, Ishimatsu Y, Fukuoka J, Mukae H: Pulmonary Langerhans cell histiocytosis diagnosed using transbronchial lung cryobiopsy: A case report. Respir Med Case Rep 46: 10928,2023.10.1016/j.rmcr.2023.101928. (IF: 1.1)
Mine K, Sakamoto N, Ozasa M, Tsutsui S, Miyashita R, Tokito T, Okuno D, Yura H, Kido T, Ishimoto H, Takemoto S, Takazono T, Obase Y, Ishimatsu Y, Fukuoka J, Mukae H: Pulmonary Langerhans cell histiocytosis diagnosed using transbronchial lung cryobiopsy: A case report. Respir Med Case Rep 46: 10928,2023.10.1016/j.rmcr.2023.101928. (IF: 1.1)
Tomono H, Taniguchi H, Fukuda M, Ikeda T, Nagashima S, Akagi K, Ono S, Umeyama Y, Shimada M, Gyotoku H, Takemoto S, Hisamatsu Y, Morinaga R, Tagawa R, Ogata R, Dotsu Y, Senju H, Soda H, Nakatomi K, Hayashi F, Sugasaki N, Kinoshita A, Mukae H.: Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study. Thorac Cancer 14(28): 2890-2894,2023.10.1111/1759-7714.15097. (IF: 2.9)
The 27th Congress of the Asian Pacific Society of Respirology
石井 寛 先生が「Efficacy and safety of nintedanib in patients with early-stage idiopathic pulmonary fibrosis: A prospective, multicenter observational cohort study in Kyushu and Okinawa, Japan」の演題で発表されました。
井手 昇太郎 先生が「Evaluation of the usefulness of the BACES score for Mycobacterial avium complex pulmonary disease」の演題で発表されました。
細萱 直希先生が「Evaluation of efficacy and safety of Lascufloxacin tablet for Nursing and Healthcare-Associated Pneumonia: single-arm, open-label clinical trial」の演題で発表されました。
山本 和子 先生が「Efficacy of clarithromycin in patients with mild COVID-19 pneumonia patients: an exploratory, multicenter, open-label, randomized controlled trial」の演題で発表されました。
髙園 貴弘 先生が「Development of a score model to predict long-term prognosis after community-onset pneumonia in older patients」の演題で発表されました。
深堀 範 先生が「Differences in therapeutic efficacy between pressurized metered-dose inhaler and dry powder inhaler for asthma patients with small airway dysfunction」の演題で発表されました。
中尾 匠 先生が「Molecular epidemiology and clinical features of pneumococcal pneumonia at a university hospital in Japan」の演題で発表されました。
山本 和子 先生が「Effect of Lactococcus lactis strain plasma (LC- Plasma) on immune response and symptoms in patients with mild COVID-19. Result of the multicenter, double- blinded, randomized controlled trial (PLATEAU study).」の演題で発表されました。
田代 将人 先生が「Prognostic Association of Liposomal Amphotericin B Doses Above 5 mg/kg in Mucormycosis: A Nationwide Epidemiologic and Treatment Analysis in Japan」の演題で発表されました。
太田 賢治先生が「The effect of SARS-CoV-2 antibody testing on the results of admission screening」の演題で発表されました。
Hirayama T, Miyazaki T, Sumiyoshi M, Ito Y, Ashizawa N, Takeda K, Iwanaga N, Takazono T, Yamamoto K, Izumikawa K, Yanagihara K, Makimura K, Tsukamoto K, Kohno S, Mukae H: Echinocandin Resistance in Candida auris Occurs in the Murine Gastrointestinal Tract Due to FKS1 Mutations. Antimicrob Agents Chemother 67(4): e0124322,2023.10.1128/aac.01243-22. (IF: 5.938)
Kiyohara M, Miyazaki T, Okamoto M, Hirayama T, Makimura K, Chibana H, Nakada N, Ito Y, Sumiyoshi M, Ashizawa N, Takeda K, Iwanaga N, Takazono T, Izumikawa K, Yanagihara K, Kohno S, Mukae H: Evaluation of a Novel FKS1 R1354H Mutation Associated with Caspofungin Resistance in Candida auris Using the CRISPR-Cas9 System. J Fungi 9(5): 529,2023.10.3390/jof9050529. (IF: 5.724)
Miyazaki T, Hosogaya N, Fukushige Y, Takemori S, Morimoto S, Yamamoto H, Hori M, Ozawa Y, Shiko Y, Inaba Y, Kurokawa T, Hanaoka H, Iwanami S, Kim K, Iwami S, Watashi K, Miyazawa K, Umeyama T, Yamagoe S, Miyazaki Y, Wakita T, Sumiyoshi M, Hirayama T, Izumikawa K, Yanagihara K, Mukae H, Kawasuji H, Yamamoto Y, Tarumoto N, Ishii H, Ohno H, Yatera K, Kakeya H, Kichikawa Y, Kato Y, Matsumoto T, Saito M, Yotsuyanagi H, Kohno S: A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19. Microbiol Spectr 11(3): e431122,2023.10.1128/spectrum.04311-22. (IF: 3.7)
Hosogaya N, Takazono T, Kurazono K, Hiroi S, Iwasaki K, Takeshima T, Ha C, Mukae H: Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan. Adv Ther : 2023.10.1007/s12325-023-02564-4. (IF: 3.8)
Hosogaya N, Takazono T, Ota K, Kiya R, Shirai Y, Kawasaki R, Yano H, Morimoto S, Nakao R, Kanamaru Y, Yoshino Y, Ishikawa Y, Fukushima C, Yamamoto H, Izumikawa K, Yanagihara K, Mukae H: Evaluation of efficacy and safety of lascufloxacin for nursing and healthcare associated pneumonia: single-arm, open-label clinical trial: A study protocol. Medicine（Baltimore） 102(8): e33092,2023.DOI: 10.1097/MD.0000000000033092. (IF: 1.817)
Takao D, Takeda K, Takazono T, Ozasa M, Ito Y, Ashizawa N, Hirayama T, Iwanaga N, Takemoto S, Ide S, Tashiro M, Hosogaya N, Kido T, Sakamoto N, Obase Y, Okano S, Izumikawa K, Yanagihara K, Mukae H: A case of drug-induced organizing pneumonia causec by amikacin liposome inhalation suspension. J Infect Chemother : 2023.10.1016/j.jiac.2023.04.013. (IF: 2.065)
Takemoto S, Ozasa M, Mizuta R, Tagawa R, Ono S, Honda N, Suyama T, Umeyama Y, Dotsu Y, Gyotoku H, Yamaguchi H, Yamamoto K, Sakamoto N, Obase Y, Fukuda M, Mukae H: Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsy. Lung Cancer
Management 11(4): 2023.NA. (IF: NA)
Shimada M, Taniguchi H, Yamaguchi H, Gyotoku H, Sasaki D, Kaku N, Senju C, Senju H, Imamura E, Takemoto S, Yamamoto K, Sakamoto N, Obase Y, Tsuchiya T, Fukuda M, Soda H, Ashizawa K, Fukuoka J, Nagayasu T, Yanagihara K, Mukae H: Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets. Transl Lung Cancer Res 12(4): 707-718,2023.10.21037/tlcr-22-794. (IF: 4.726)
Ashizawa H, Iwanaga N, Kurohama H, Ito Y, Ashizawa N, Hirayama T, Takeda K, Ide S, Nagayoshi Y, Tashiro M, Takazono T, Tagawa T, Fukushima K, Ito M, Nakamura S, Izumikawa K, Yanagihara K, Miyazaki Y, Mukae H.: Pulmonary coccidioidomycosis complicated by nontuberculous mycobacterial pulmonary diseases with a literature review.. Jpn J Infect Dis : 2023.10.7883/yoken.JJID.2023.073. (IF: 2.541)
岩永 直樹先生が「Suppression by Clarithromycin of IL-8 Production from Human Airway Epithelial Cells Treated with Prevotella Intermedia Supernatants」の演題で発表されました。
城戸 貴志先生が「Evaluation of procedures for obtaining cilia and quantitative parameters of ciliary beat obtained by nasal brushing for the diagnosis of primary ciliary dyskinesia」の演題で発表されました。
時任 高諄先生が「Effects of Administering Intravenous Azithromycin Within 7 Days of Hospitalization on Influenza Virus Pneumonia Complicated with ARDS: A Propensity Score Analysis Using a Nationwide Administrative Database」の演題で発表されました。
芦澤 博貴先生が「Exacerbation of oral Streptococci-induced pneumonia by Prevotella intermedia depends on the type IX secretion system」の演題で発表されました。
奥野 大輔先生が「Human vγ2vδ2 T Cells Attenuate Collagen Type I Expression in Lung Fibroblasts By Inhibiting Myocardin Expression」の演題で発表されました。
山本 和子先生が「Bacterial Coinfections in COVID-19 Patients With Acute Respiratory Failure: Japan National Registry Survey」の演題で発表されました。
Tagawa R , Soda H, Dotsu Y, Senju H, Irifune S, Yoshida M, Nakashima S, Umemura A, Iwasaki K, Taniguchi H, Takemoto S, Fukuda Y, Mukae H: Hypertrophic osteoarthropathy associated with lung cancer: Possible links among hypoxia-inducible factor-1α, vascular endothelial growth factor, and hypervascularization. Thorac Cancer : 2023.
Akagi K, Yagishita S, Ohuchi M, Hayashi Y, Takeyasu Y, Masuda K, Shinno Y, Okuma Y, Yoshida T, Goto Y, Horinouchi H, Yamamoto N, Mukae H, Ohe Y, Hamada A: Impact of ramucirumab pharmacokinetics in combination with docetaxel on the efficacy and survival in patients with advanced non-small cell lung cancer.. Lung Cancer 178: 247-253,2023.10.1016/j.lungcan.2023.03.001. (IF: 6.081)
Umeyama Y, Taniguchi H, Gyotoku H, Senju H, Tomono H, Takemoto S, Yamaguchi H, Tagod MSO, Iwasaki M, Tanaka Y, Mukae H.: Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma. Front Immunol. 14: 1058838,2023.doi: 10.3389/fimmu.2023.1058838. . (IF: 8.787)
Umeyama Y, Taniguchi H, Yamaguchi H, Shimada M, Sugasaki N, Kinoshita A, Hayashi T, Abe K, Ono S, Gyotoku H, Senju H, Ikeda T, Katsumi N, Fukuda M, Takemoto S, Mukae H.: Severe esophagitis directly induced by accumulation of crizotinib-residue at the esophageal mucosa proven with polarizing microscope examination. ACTA MEDICA NAGASAKIENSIA 66(2): 99-103,2023.NA. (IF: NA)
Iwanaga N, Devarajan P, Shenoy AT.: Editorial: Adaptive Immunity to Respiratory Pathogens. Front Immunol 14: 1174178,2023.doi: 10.3389/fimmu.2023.1174178.. (IF: 8.787)
Fukahori S, Han J, Vera I, Lockey R, Kim K, Cho S: Elevated PAI-1 Levels Are Associated With Severe COVID-19. J Allergy Clin Immunol 151(2): AB190 ,2023.10.1016/j.jaci.2022.12.595. (IF: 14.29)
Noguchi R, Yoshimura A, Uchino J, Takeda T, Chihara Y, Ota T, Hiranuma O, Gyotoku H, Takayama K, Kondo T: Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations.. Proteomes 11(1): 2023.10.3390/proteomes11010006. (IF: 3.76)
Fukahori S, Cho S, Obase Y, Fukushima C, Mukae H, Lockey R: Differences In Therapeutic Efficacy Between Pressurized Metered-dose Inhaler And Dry Powder Inhaler For Asthma Patients With Small Airway Dysfunction. J Allergy Clin Immunol 151(2): AB337,2023.10.1016/j.jaci.2022.12.787. (IF: 14.29)
Han J, Moon A, Tabor M, Fukahori S, Lockey R, Cho S: Increased Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM 5) Production and Its Role in Human Nasal Polyps. J Allergy Clin Immunol 151(2): AB107,2023.10.1016/j.jaci.2022.12.341. (IF: 14.29)
Zaizen Y, Okamoto M, Azuma K, Fukuoka J, Hozumi H, Sakamoto N, Suda T, Mukae H, Hoshino T: Enhanced immune complex formation in the lungs of patients with dermatomyositis. Respir Res 24(1): 86,2023.10.1186/s12931-023-02362-0. (IF: 7.162)
Koji K, Kanako S, Minoru F, Yumiko S Hiroyuki Y, Shinnosuke T, Katsuhiko S, Takeshi M, Katsumi N, Shigeo K, Ryo T, Takayuki S, Keiko M, Takehiro H, Yusuke At, Yasuhiro I, Toshiyuki S, Hiromasa I, Noboru H, Eiichiro K, Masao N, Hiroshi M, Toru O, Mikio O: Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers. Adv Clin Chem
112: 155-204,2023.doi: 10.1016/bs.acc.2022.09.004. Epub 2022 Nov 17.. (IF: 6.303)
Akihiro Y, Tadaaki Y, Masakuni S, Hisanori U, Keiko T, Yusuke O, Akito F, Satoshi W, Naoya N, Takayuki T, Yusuke C, Shinnosuke T, Taishi H, Osamu H, Yukina S, Takehito S, Akihiro N, Yasuhiro G, Shinsuke S, Kei K, Kenji M, Yuki K, Kenichi S, Tetsuya M, Seiji Y, Hirotsugu K, Toshiaki T, Koichi T: High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinib. Cancer Sci 114(2): 606-618,2023.doi: 10.1111/cas.15608.. (IF: 6.518)
Tokito T, Sakamoto N, Ishimoto H, Okuno D, Miyamura T, Hara A, Kido T, Yamamoto K, Yamaguchi H, Obase Y, Akazawa Y, Okamura K, Suzuki T, IshimatsuY, Mukae H: Pulmonary and Intestinal Involvement in a Patient with Myeloperoxidase-specific Antineutrophil Cytoplasmic Antibody-positive Hermansky-Pudlak Syndrome. Intern Med 62(1): 103-106,2023.doi: 10.2169/internalmedicine.9350-22. (IF: 1.27)
Setoguchi D, Iwanaga N, Ito Y, Ashizawa N, Hirayama T, Takeda K, Ide S, Takemoto S, Tashiro M, Hosogaya N, Takazono T, Sakamoto N, Obase Y, Izumikawa K, Yanagihara K, Mukae H. : Pulmonary phaeohyphomycosis due to Exophiala dermatitidis in a patient with pulmonary non-tuberculous mycobacterial infection. J Infect Chemother : 2023. (IF: 2.065)
菅崎 七枝先生が「Phase II study of ramucirumab and docetaxel for platinum-resistance NSCLC patients with malignant pleural effusion: Analysis of pleural effusion control rate」の演題で発表されました。
Mori M, Kido T, Sakamoto N, Ozasa M, Kido K, Noguchi Y, Tokito T, Okuno D, Yura H, Hara A, Ishimoto H, Suematsu T, Obase Y, Tanaka Y, Izumikawa K, Takeuchi K, Mukae H. : Novel SPEF2 Variant in a Japanese Patient with Primary Ciliary Dyskinesia: A Case Report and Literature Review. J Clin Med 12(1): 317,2023. (IF: 4.964)
Kurose K, Sakaeda K, Fukuda M, Sakai Y, Yamaguchi H, Takemoto S, Shimizu K, Masuda T, Nakatomi K, Kawase S, Tanaka R, Suetsugu T, Mizuno K, Hasegawa T, Atarashi Y, Irino Y, Sato T, Inoue H, Hattori N, Kanda E, Nakata M, Mukae H, Oga T, Oka M.: Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers. Adv Clin Chem. 112: 155-204,2023. (IF: 5.394)
Taniguchi H, Akagi K, Dotsu Y, Yamada T, Ono S, Imamura E, Gyotoku H, Takemoto S, Yamaguchi H, Sen T, Yano S, Mukae H.: Pan-HER inhibitors overcome lorlatinib resistance caused by NRG1/HER3 activation in ALK-rearranged lung cancer. Cancer Sci 114(1): 164-173,2023. (IF: 6.518)
